Insider · CIK 0001909000
Karen Matusinec
Files at ZIMV (ZimVie Inc.). First filing -, latest -.
In brief
Karen Matusinec files SEC Form 4 as director at ZIMV (ZimVie Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Karen Matusinec has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | ZIMV ZimVie Inc. | DDisposition to issuer Deferred Share Unitsderivative | -6,756 | - | - | 0 | Oct 20, 2025 |
| Oct 20, 2025 | ZIMV ZimVie Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -57,728 | - | - | 0 | Oct 20, 2025 |
| May 7, 2025 | ZIMV ZimVie Inc. | AGrant or award Deferred Share Unitsderivative | +500 | $0.00 | $0 | 6,756 | May 9, 2025 |
| May 7, 2025 | ZIMV ZimVie Inc. | AGrant or award Restricted Stock Unitsderivative | +21,119 | $0.00 | $0 | 57,728 | May 9, 2025 |
Questions about Karen Matusinec
Answered from the filings on this page, as of the latest one.
Is Karen Matusinec buying or selling?
Karen Matusinec has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Karen Matusinec's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karen Matusinec has 0.
Where does Karen Matusinec file Form 4?
Karen Matusinec has filed Form 4 at ZIMV (ZimVie Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.